224 related articles for article (PubMed ID: 27966523)
1. Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein.
Gardner TJ; Stein KR; Duty JA; Schwarz TM; Noriega VM; Kraus T; Moran TM; Tortorella D
Nat Commun; 2016 Dec; 7():13627. PubMed ID: 27966523
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
[TBL] [Abstract][Full Text] [Related]
4. Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies.
Ai Y; Wu C; Zhang M; Jaijyan DK; Liu T; Zan L; Li N; Yu W; Wang Y; Yuan X; Li C; Zheng W; Zhu H; Liao HX
Microbiol Spectr; 2022 Dec; 10(6):e0139322. PubMed ID: 36342276
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L.
He L; Taylor S; Costa C; Görzer I; Kalser J; Fu TM; Freed D; Wang D; Cui X; Hertel L; McVoy MA
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891489
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
7. Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism.
Zhou M; Lanchy JM; Ryckman BJ
J Virol; 2015 Sep; 89(17):8999-9009. PubMed ID: 26085146
[TBL] [Abstract][Full Text] [Related]
8. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
[TBL] [Abstract][Full Text] [Related]
9. Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
Gardner TJ; Tortorella D
Microbiol Mol Biol Rev; 2016 Sep; 80(3):663-77. PubMed ID: 27307580
[TBL] [Abstract][Full Text] [Related]
10. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
Choi KY; McGregor A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
[TBL] [Abstract][Full Text] [Related]
11. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
[TBL] [Abstract][Full Text] [Related]
12. Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies.
Ciferri C; Chandramouli S; Leitner A; Donnarumma D; Cianfrocco MA; Gerrein R; Friedrich K; Aggarwal Y; Palladino G; Aebersold R; Norais N; Settembre EC; Carfi A
PLoS Pathog; 2015 Oct; 11(10):e1005230. PubMed ID: 26485028
[TBL] [Abstract][Full Text] [Related]
13. Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes.
Ciferri C; Chandramouli S; Donnarumma D; Nikitin PA; Cianfrocco MA; Gerrein R; Feire AL; Barnett SW; Lilja AE; Rappuoli R; Norais N; Settembre EC; Carfi A
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1767-72. PubMed ID: 25624487
[TBL] [Abstract][Full Text] [Related]
14. Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.
Schultz EP; Lanchy JM; Ellerbeck EE; Ryckman BJ
J Virol; 2015 Dec; 90(5):2294-305. PubMed ID: 26656708
[TBL] [Abstract][Full Text] [Related]
15. Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism.
Nguyen CC; Kamil JP
Viruses; 2018 Dec; 10(12):. PubMed ID: 30544948
[TBL] [Abstract][Full Text] [Related]
16. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.
Freed DC; Tang Q; Tang A; Li F; He X; Huang Z; Meng W; Xia L; Finnefrock AC; Durr E; Espeseth AS; Casimiro DR; Zhang N; Shiver JW; Wang D; An Z; Fu TM
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4997-5005. PubMed ID: 24297878
[TBL] [Abstract][Full Text] [Related]
17. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.
Fouts AE; Comps-Agrar L; Stengel KF; Ellerman D; Schoeffler AJ; Warming S; Eaton DL; Feierbach B
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8209-14. PubMed ID: 24843144
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
[TBL] [Abstract][Full Text] [Related]
20. The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.
Liu J; Jardetzky TS; Chin AL; Johnson DC; Vanarsdall AL
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
